North America Western Blotting Market
North America Western Blotting Market Projected to Reach $404.96 Million by 2027, Growing at a 5.4% CAGR
The North America western blotting market, valued at $257.05 million in 2018, is anticipated to grow to $404.96 million by 2027, registering a compound annual growth rate (CAGR) of 5.4% from 2019 to 2027. Key drivers of this growth include increasing investments in proteomic research and the rising prevalence of diseases such as Lyme and HIV. However, the adoption of alternative protein detection technologies may restrain market expansion in the region.
📚Download Full PDF Sample Copy of Market Report @
https://wwcw.businessmarketinsights.com/sample/TIPRE00006462
Key Market Drivers
1. Rising Prevalence of Lyme Disease
Western blotting plays a crucial role in diagnostic testing, particularly for Lyme disease, a tick-borne illness increasingly prevalent in North America. A 2018 study by Carnegie Mellon University highlighted that climate change is contributing to the growing incidence of Lyme disease in the U.S. Western blot IgM testing has demonstrated high specificity (94-96%) in patients exhibiting clinical symptoms of Lyme disease, reinforcing its diagnostic importance.
2. Increasing HIV/AIDS Cases
The global rise in HIV/AIDS cases has further propelled the demand for western blotting. HIV, which leads to acquired immunodeficiency syndrome (AIDS), severely compromises the immune system. According to the U.S. Department of Health & Human Services, approximately 36.9 million people worldwide were living with HIV/AIDS in 2017, with a significant burden in low- and middle-income countries.
In the U.S., around 38,700 new HIV infections were reported in 2016 (HIV.gov). Western blotting remains a gold-standard confirmatory test for HIV, following initial ELISA screening. This diagnostic necessity is expected to sustain market growth in the coming years.
Market Challenges
The adoption of alternative protein detection technologies, such as mass spectrometry and ELISA-based assays, may hinder the growth of the western blotting market. These methods offer faster and more automated solutions, posing competition to traditional western blotting techniques.
Regional Market Outlook
The U.S. is poised to dominate the North American western blotting market, driven by advancements in biotechnology, robust R&D activities in diagnostics, and the country's leadership in biotech-derived agricultural exports. These factors position the U.S. as the largest contributor to regional market growth during the forecast period.
North America Western Blotting Strategic Insights
Strategic insights for the North America Western Blotting provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
key company profiles
Thermo Fisher Scientific Inc.
Merck KGaA,
GENERAL ELECTRIC
Cell Signaling Technology, Inc.
PerkinElmer, Inc.
Bio-Rad Laboratories, Inc.
LI-COR, Inc.
OriGene Technologies, Inc.,
Rockland Immunochemicals Inc.
Abcam plc
Regional Insights on Western Blotting in North America
The geographic scope of Western Blotting in North America encompasses the specific regions where businesses operate and compete. Recognizing regional differences—such as varying customer needs (e.g., preferred equipment specifications or technical requirements), economic factors, and regulatory standards—is essential for customizing strategies to local markets. Companies can enhance their market presence by pinpointing underserved regions or modifying their products and services to align with regional demands. A well-defined regional focus enables more efficient resource allocation, tailored marketing efforts, and stronger competitive positioning, ultimately fostering growth in targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author's Bio
Akshay
Senior Market Research Expert at Business Market Insights
Comments
0 comment